Animal studies years ago hinted at atropine’s ability to slow the growth of the eye, but the full-strength drug’s interference with near vision and concerns about pupil dilation hindered early considerations of its potential as a human therapy for myopia.

Source: https://www.canindia.com/eye-drops-slow-nearsightedness-progression-in-kids-study/